Cargando…

Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus

BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen, Tong, Jiaqi, Tang, Mengqiu, Lu, Yunyun, Liang, Gaofeng, Zhang, Zhanchun, Chen, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872927/
https://www.ncbi.nlm.nih.gov/pubmed/33574705
http://dx.doi.org/10.2147/CMAR.S294344
_version_ 1783649284307025920
author Wang, Chen
Tong, Jiaqi
Tang, Mengqiu
Lu, Yunyun
Liang, Gaofeng
Zhang, Zhanchun
Chen, Tian
author_facet Wang, Chen
Tong, Jiaqi
Tang, Mengqiu
Lu, Yunyun
Liang, Gaofeng
Zhang, Zhanchun
Chen, Tian
author_sort Wang, Chen
collection PubMed
description BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous cell carcinoma (ESCC) located in the middle or upper region is still inconclusive. The aim of the study was to examine pretreatment NLR and PLR to select from radical surgery or definitive chemoradiotherapy (dCRT) for these patients. The linkage between pretreatment NLR/PLR and prognosis was also analyzed. METHODS: NLR and PLR were calculated in 113 locally advanced ESCC located in the middle or upper esophagus of patients who underwent radical surgery or dCRT between January 2014 and December 2019. A receiver operating characteristic curve was plotted to select the best cut-off value of NLR and PLR for predicting survival. A survival curve was plotted using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were applied to assess predictors for survival. RESULTS: NLR and PLR were associated with the extent of lymph node metastasis (NLR: P = 0.045; PLR: P = 0.002). Additionally, high PLR and recurrence with distant organ metastasis were closely related (P = 0.014), and NLR was related to the tumor stage (P = 0.043). The results of the multivariate analysis revealed that NLR (>2.07) and PLR (>183.06) were independently associated with poor prognosis. It is noteworthy that surgery was associated with a superior OS compared with dCRT in the low NLR population (P = 0.045). CONCLUSION: Low pretreatment NLR patients are fit to undergo radical surgery with a substantial therapeutic benefit. Pretreatment NLR and PLR are independent predictors for patients with locally advanced ESCC located in the middle and upper esophagus who underwent radical surgery or dCRT.
format Online
Article
Text
id pubmed-7872927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78729272021-02-10 Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus Wang, Chen Tong, Jiaqi Tang, Mengqiu Lu, Yunyun Liang, Gaofeng Zhang, Zhanchun Chen, Tian Cancer Manag Res Original Research BACKGROUND: Various inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), have been well authenticated to predict clinical outcomes in numerous types of cancer. The optimal treatment for patients with locally advanced esophageal squamous cell carcinoma (ESCC) located in the middle or upper region is still inconclusive. The aim of the study was to examine pretreatment NLR and PLR to select from radical surgery or definitive chemoradiotherapy (dCRT) for these patients. The linkage between pretreatment NLR/PLR and prognosis was also analyzed. METHODS: NLR and PLR were calculated in 113 locally advanced ESCC located in the middle or upper esophagus of patients who underwent radical surgery or dCRT between January 2014 and December 2019. A receiver operating characteristic curve was plotted to select the best cut-off value of NLR and PLR for predicting survival. A survival curve was plotted using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were applied to assess predictors for survival. RESULTS: NLR and PLR were associated with the extent of lymph node metastasis (NLR: P = 0.045; PLR: P = 0.002). Additionally, high PLR and recurrence with distant organ metastasis were closely related (P = 0.014), and NLR was related to the tumor stage (P = 0.043). The results of the multivariate analysis revealed that NLR (>2.07) and PLR (>183.06) were independently associated with poor prognosis. It is noteworthy that surgery was associated with a superior OS compared with dCRT in the low NLR population (P = 0.045). CONCLUSION: Low pretreatment NLR patients are fit to undergo radical surgery with a substantial therapeutic benefit. Pretreatment NLR and PLR are independent predictors for patients with locally advanced ESCC located in the middle and upper esophagus who underwent radical surgery or dCRT. Dove 2021-02-05 /pmc/articles/PMC7872927/ /pubmed/33574705 http://dx.doi.org/10.2147/CMAR.S294344 Text en © 2021 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Chen
Tong, Jiaqi
Tang, Mengqiu
Lu, Yunyun
Liang, Gaofeng
Zhang, Zhanchun
Chen, Tian
Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title_full Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title_fullStr Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title_full_unstemmed Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title_short Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus
title_sort pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors and reference markers of treatment options for locally advanced squamous cell carcinoma located in the middle and upper esophagus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872927/
https://www.ncbi.nlm.nih.gov/pubmed/33574705
http://dx.doi.org/10.2147/CMAR.S294344
work_keys_str_mv AT wangchen pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT tongjiaqi pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT tangmengqiu pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT luyunyun pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT lianggaofeng pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT zhangzhanchun pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus
AT chentian pretreatmentneutrophiltolymphocyteratioandplatelettolymphocyteratioasprognosticfactorsandreferencemarkersoftreatmentoptionsforlocallyadvancedsquamouscellcarcinomalocatedinthemiddleandupperesophagus